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HIS FINAL CHAPTER AIMS to summarize the main findings of the dif-
ferent studies of this thesis about the neuroendocrinological fac-
tors affecting gender identity and the sexual differentiation of the 
brain and behavior. Methodological considerations and implica-
tions are discussed in light of the existing literature. The discussion will con-
clude with recommendations for the clinical practice and future research. 
The specific aims of this dissertation were threefold. First, we examined 
whether and to what extent the neurobiological characteristics of a group of 
young individuals, diagnosed with Gender Dysphoria (GD), reflected their 
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expressed/experienced gender, rather than their natal sex. As a second objec-
tive, we investigated whether pre-/perinatal and pubertal sex hormones exert 
any organizational and/or activational effects on sex differences of brain struc-
ture and function. Our third aim was to explore the contribution of (cross-) sex 
hormones to the development of sex differences in neuroanatomy and brain 
function.  
The studies described in this thesis had as main objective to test the 
hypothesis of an altered sexual differentiation in – young – individuals with 
GD, and thus whether variations in sex hormones during critical periods of 
sexual differentiation contribute to the development of GD in childhood and 
adolescence. 
Summary of the main findings
part 1
A RETROSPECTIVE WINDOW TO EARLY ANDROGEN  
EXPOSURE - OTOACOUSTIC EMISSIONS
IN CHAPTER 2 WE measured click-evoked otoacoustic emissions (CEOaEs), i.e. echo-
like sounds produced by the inner ear, showing generally higher response am-
plitudes in females, in a group of treatment-naïve children and adolescents 
with GD (24 natal boys, 23 natal girls) and control subjects (65 boys and 62 girls). 
Weaker responses in males were proposed to originate from elevated levels of 
testosterone during prenatal male sexual differentiation. Therefore, we em-
ployed CEOaE recordings in order to retrospectively estimate the potentially 
aberrant prenatal hormone environment of children with GD. We replicated the 
normative sex difference in CEOaE response amplitude, with significantly 
stronger emissions in the control girls compared to control boys. This sex dif-
ference, however, was absent in the gender dysphoric boys and girls. Boys with 
GD showed stronger, more female-typical CEOaEs, whereas girls with GD did 
not differ in emission strength compared with control girls. Based on the as-
sumption that CEOaE amplitudes can be seen as an index of the relative prena-
tal androgen exposure, our findings provide some evidence for the idea that 
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boys with GD may have been exposed to relatively lower amounts of androgen 
during early development. 
In ChaptEr 3, based on the assumption that sex hormones may also exert 
activational, postnatal effects on CEOaEs, we examined whether hormonal in-
terventions (gonadotropin-releasing hormone analogs (Gnrha) for pubertal sup-
pression or cross-sex hormone (CSh) treatment) in 43 natal boys and 62 natal 
girls, all diagnosed with GD, affected their CEOaEs. We hypothesized that sup-
pression of endogenous testosterone production (by means of Gnrha) and ad-
ministration of estradiol in natal males would result in stronger emissions, and 
thus in female-typical CEOaE response amplitudes in boys with GD. Conversely, 
suppressing endogenously high levels of estradiol (by means of Gnrha) and the 
administration of testosterone in natal females was assumed to result in dimin-
ished CEOaEs in girls with GD. Sex hormone suppression by means of Gnrha 
resulted in weaker CEOaEs, especially when suppressing endogenous estradiol 
levels in natal females. In line with the assumed diminishing effects of andro-
gens on CEOaEs, natal girls who received testosterone treatment showed sig-
nificantly weaker right ear CEOaEs compared with treatment-naïve natal girls. 
Contrary to our expectations, left ear CEOaEs in natal boys receiving estradiol 
administrations were also weaker than those of their treatment-naïve peers. 
Our findings suggest that both testosterone and estradiol seemed to be actively 
implicated in facilitating or inhibiting the cochlear amplification mechanism. 
We propose that postnatal variations in CEOaE amplitude are mediated by es-
tradiol-regulated mechanisms, and that androgens are first aromatized into es-
tradiol, in order to actively masculinize CEOaEs.
part 2
THE CHEMO-SIGNAL ANDROSTADIENONE 
SNIFFING THE SEX OF THE BRAIN
THE ODOROUS STEROID COMPOUND androstadienone, a putative male chemo-signal 
that is found in axillary sweat, was previously reported to evoke hypothalamic 
activations in heterosexual women, but not in heterosexual men. Since an-
drostadienone is centrally processed without any conscious awareness, investi-
gating brain responses during exposure to the chemo-signal offers a relatively 
simple and objective experimental procedure for investigating functional sex 
differences in the human brain. In ChaptEr 4 we applied this method using 
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functional magnetic resonance imaging (f MrI) with the intention to replicate pre-
vious studies using positron emission tomography. Twenty-one women and 16 
men, all heterosexual, were exposed to three different concentrations of an-
drostadienone, in order to test whether the sex difference in response to the 
steroid odor was dose-dependent. Surprisingly, we found that both men and 
women showed hypothalamic activation when smelling androstadienone. In 
line with previous findings, women showed a stronger response compared with 
men when they were exposed to the high androstadienone concentration. How-
ever, a stronger hypothalamic response in heterosexual men compared with 
women, when exposed to the medium androstadienone concentration was un-
expected, and points to the need for a more thorough investigation of possible 
behavioral and/ or physiological actions of this steroid compound in heterosex-
ual men. 
Based on the results of the study described in ChaptEr 4, we decided to 
use the high androstadienone concentration for the study described in 
ChaptEr 5, in which we investigated whether puberty and gender identity 
modulated the sex difference in hypothalamic response to androstadienone. 
We measured brain activation during exposure to the chemo-signal in 39 pre-
pubertal and 41 adolescent boys and girls, and then investigated whether 36 
prepubertal children and 38 adolescents diagnosed with GD exhibited sex-atyp-
ical, rather than sex-typical hypothalamic activations during olfactory stimula-
tion with androstadienone. We showed that the sex difference in hypothalamic 
responsiveness to androstadienone was already present in prepubertal chil-
dren, and thus likely developed during early development instead of during 
sexual maturation. Hypothalamic responses in both adolescent girls and boys 
with GD were remarkably similar to those of their experienced gender control 
groups, thus sex-atypical. In contrast, we found no evidence for sex-atypical 
neuronal processing of the chemo-signal in prepubertal boys with GD, while 
the young girls with GD showed neither a typically male nor typically female 
response pattern to androstadienone. The future persistence of GD into adult-
hood in the younger age groups will supposedly be relatively lower compared 
to the adolescent groups who already started using Gnrha. Therefore, we spec-
ulate that the prepubertal groups are more heterogeneous with regard to their 
future GD diagnosis, which in turn may hamper clear-cut results regarding 
their sex-typical or sex-atypical response to androstadienone. Our findings in 
the prepubertal GD samples, in light of the distinct sex differences in the prepu-
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bertal controls and the robust sex-reversed pattern of activation in the adoles-
cents with GD, suggest that factors (i.e. hormonal and/or psychological, 
environmental) other than early pre-/perinatal mechanisms of sexual differen-
tiation may impact a non-normative gender identity development into adoles-
cence. 
part 3
EFFECTS OF SEX HORMONES ON BRAIN STRUCTURE  
& FUNCTION IN ADOLESCENCE
DIFFUSION TENSOR IMAGING HAS been applied as a powerful magnetic resonance 
technique to map the three-dimensional diffusion of water in brain tissue. Dif-
fusion measures are highly sensitive to changes of white matter cellular archi-
tecture, and have therefore been used to characterize changes in 
neurodevelopmental microstructural white matter. White matter diffusion 
characteristics were found to vary as a function of gender, suggesting differenc-
es in axonal organization and myelination between the sexes. In addition, pu-
bertal development and circulating sex hormone levels were differentially 
associated with white matter diffusion characteristics in males and females. In 
ChaptEr 6, we investigated whether 21 adolescent girls and 17 adolescent boys, 
diagnosed with GD exhibited sex-atypical, rather than sex-typical white matter 
microstructural characteristics. We first identified several brain regions show-
ing sex differences in white matter diffusion parameters in controls (21 girls 
and 20 boys). Then, we compared the mean diffusion values for each of these 
regions between groups. Boys with GD, who were receiving Gnrha, had inter-
mediate values relative to control males and females in the majority of these 
brain areas, indicating that they showed neither full feminization nor full mas-
culinization. This suggests that males with early onset GD may have had insuffi-
cient masculinization of their white matter fiber tissue during brain 
development, supporting the hypothesis of an atypical early sexual differentia-
tion of the brain in individuals with GD. In contrast, girls with GD, also using 
Gnrha, had predominantly sex-typical white matter diffusion characteristics 
showing only slight masculinization in fiber organization. Our findings are at 
odds with a previous study showing that adult treatment-naïve women with GD 
had significantly masculinized white matter fiber organization. We therefore 
assume that variables such as sex hormones, natal sex, and GD diagnosis may 
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interact differently during adolescent brain maturation as compared with the 
adult situation.
In ChaptEr 7 a prospective f MrI study examining the effects of testoster-
one treatment on visuo-spatial cognitive functions in 21 adolescent girls with 
GD is described. A classical cognitive task eliciting robust behavioral sex differ-
ences, the mental rotation task, was performed twice by the natal girls with GD: 
after having received Gnrha for some time to suppress their endogenous sex 
hormones, just before the onset of cross-sex hormone treatment with testoster-
one, and then 10 months later while receiving testosterone. Two control groups 
of 20 boys and 21 girls participated twice as well. Thereby, within-subject effects 
other than the testosterone treatment, such as learning effects between ses-
sions, or cognitive development, were accounted for. Between-group compari-
sons before the onset of the testosterone treatment suggested a more 
male-typical brain activation pattern in the girls with GD when performing the 
mental rotation task. Ten months after the start of testosterone administration, 
in a similar fashion as the control boys, girls with GD showed an increase in 
mental rotation task-associated brain activation compared with the pre-testos-
terone scan. Our findings thus suggest a priori masculinized visuo-spatial cog-
nitive functions in girls with GD. In addition, we provide new evidence for 
activational effects of testosterone on visuo-spatial cognitive functioning. 
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Summary of the Main Findings 
CHAPTER 2
aIM Estimate, retrospectively, prenatal androgen exposure in treatmentnaïve 
children & adolescents with GD, by means of CEOaEs recordings.
MaIn finDInGS A significant sex difference in CEOaE response amplitude, 
present in the control groups, was not observed in boys and girls with GD. Boys 
with GD showed demasculinized (stronger), though not fully feminized (lower 
than control girls) CEOaE response amplitudes in comparison to controls. Girls 
with GD had sex-typical CEOaE strengths, similar to control girls.
CHAPTER 3
aIM Assuming sex hormones exert activational effects on CEOaEs, we exam-
ined whether the hormonal interventions (Gnrha and CSh treatment) in indi-
viduals with GD affected their CEOaEs 
MaIn finDInGS Sex hormone suppression had dampening effects on CEOaEs 
in the natal girls. Testosterone administration in natal girls and estradiol treat-
ment in natal boys both had diminishing effects on CEOaEs.
CHAPTER 4
aIM Determine whether the chemo-signal androstadienone elicits sex-specific 
and dose-dependent effects on hypothalamic activation.
MaIn finDInGS Women showed a stronger response to androstadienone than 
men, when exposed to the highest concentration of the steroid odor, whereas 
men showed stronger responses to the lower concentrations of androstadien-
one compared with women. 
CHAPTER 5
aIM Determine whether the sex difference in hypothalamic response to an-
drostadienone could be observed in prepubertal children, and whether children 
and adolescents with GD (receiving GnRHa) showed sex-atypical rather than 
sex-typical responses to the steroid odor.
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MaIn finDInGS Prepubertal girls, similar to adolescent and adult females, re-
sponded significantly stronger to androstadienone by means of hypothalamic 
activation than males, suggesting a hardwired functional sex difference of the 
brain. Adolescents with GD, both natal boys and natal girls, showed hypotha-
lamic activations in accordance with their experienced gender, whereas the re-
sponse of prepubertal boys with GD reflected their natal sex, and prepubertal 
girls with GD showed neither a typically male nor typically female response.   
CHAPTER 6
aIM Investigate white matter diffusion characteristics of adolescent boys and 
girls with GD (receiving Gnrha) in predefined white matter brain areas show-
ing sex differences in age-matched control groups 
MaIn finDInGS Adolescent boys with GD had diffusion values that were inter-
mediate to those of the control girls and control boys. Adolescent girls with GD 
showed a predominantly female-typical white matter microstructure.  
CHAPTER 7
aIM Compare a group of adolescent girls with GD (receiving Gnrha) to male 
and female controls with regard to visuo-spatial cognitive functioning and as-
sociated brain activation; determine the effects of testosterone treatment on 
visuo-spatial cognition
MaIn finDInGS Girls with GD showed a priori masculinized visuo-spatial 
functioning, prior to the start of the testosterone treatment and while receiving 
Gnrha. Similar to control boys, girls with GD show testosterone-related in-
creases in task-related brain activations after 10 months of testosterone admin-
istration.
  
CEOAE = click-evoked otoacoustic emissions; GD = Gender Dysphoria;  
GnRHa = gonadotropin-releasing hormone analog; CSH = cross-sex hormone
